Skip to main content

Prompting vs Keywording: How Answer Engine Optimization Is Rewriting Pharma Search

June 10, 2026
Prompting vs Keywording

For two decades, search meant keywords. A healthcare professional typed three or four words into Google, scanned a page of blue links, and clicked. Marketing teams built entire content programmes around that behaviour: research the keyword, match the intent, win the ranking, earn the click. That model is now breaking, search is shifting from keywords to prompts in LLMs.

The shift has a name. People no longer keyword; they prompt. Instead of typing “SGLT2 inhibitor heart failure,” a cardiologist now asks an AI assistant a full conversational question and receives a synthesised, cited answer without ever visiting a website. The discipline that governs visibility in this new environment is Answer Engine Optimization, and it demands a different playbook from the one most pharma marketing teams still run.

This article explains what answer engine optimization is, how prompting differs from keywording at a behavioural level, and what a compliant, effective AEO strategy looks like when you operate inside a regulated industry.

What is answer engine optimization?

Answer engine optimization (AEO) is the practice of structuring content so that AI-powered search engines and large language models cite it directly in their generated answers. Where traditional SEO optimises for a ranked list of links, AEO optimises to be the answer itself — the source a generative AI system quotes when a user prompts it in natural language, matching user intent and answering user queries directly.

From Keywords to Prompts: The Behavioural Shift Behind the Acronym

To understand AEO you have to understand what changed in user behaviour. The acronym is new; the shift underneath it is structural.

How keyword search worked

Traditional search engines were lexical matching machines. Users compressed their intent into a handful of keywords, the engine matched those tokens against indexed web pages, and a ranked list of results came back. The entire SEO industry grew up optimising for that mechanic: keyword research identified the terms, on-page optimisation matched them, and domain authority plus backlinks decided who ranked. The user did the synthesis. They opened several pages, compared them, and drew their own conclusion.

That model produced a predictable funnel. Impressions led to clicks, clicks led to sessions, sessions led to conversions, and every step was measurable in Google Analytics. Keywording was a transaction between a query and a list.

The shift: How prompt-based search works

AI search engines invert the model. A user issues a conversational query in natural language — often a full sentence or a multi-part question with several goals embedded in it — and the system uses natural language processing and large language models to interpret intent, often relying on conversational language and increasingly resolving context from past interactions and user preferences before retrieving relevant sources and synthesising a single direct answer. The user no longer compares ten links.

They read one answer, and these systems increasingly aim to provide direct answers to user questions, whether that answer cites three sources or none.

This is the move from a query-and-list interaction to a query-synthesis-answer interaction. Google’s AI Overviews, ChatGPT, Perplexity, Claude, and Gemini all operate this way. The SEO funnel that depended on the click is collapsing into the answer surface itself. When the answer engine resolves the question in place, there is no link to click — a phenomenon now visible in the data, with a majority of mobile Google searches already ending without a click.

The core distinction

Keywording optimises for a changing search experience, where the goal is no longer just to be found in a list of results. Prompting optimises to be quoted in a generated answer.

AEO is how you move from the first to the second.

Why the shift hits pharma harder

Pharma audiences are precisely the audiences adopting prompt-based search fastest. Healthcare professionals are time-poor, evidence-driven, and increasingly comfortable asking an AI assistant to summarise prescribing considerations, mechanism of action, or comparative outcomes data.

Patients ask conversational health questions they would once have typed as fragmented keywords.

In both cases the answer engine, not your website, becomes the first point of contact with information about your therapy area. If your content is not structured to be retrieved and cited by these systems, you are absent from the conversation that increasingly replaces the search results page.

What the Data Says About AI Search Adoption

Several signals, drawn from industry research across the SEO and MarTech sector, point the same direction. Treat the specific figures below as directional indicators to validate against primary sources before citing externally, but the pattern they describe is consistent and well documented.

  • Around 90% of businesses report concern about losing online visibility as AI-driven search intermediates more of the user journey.
  • AI search is projected by multiple forecasts to surpass traditional search volume by roughly 2028.
  • AI-driven search tools currently account for an estimated 10% of referral traffic to many sites, and the share is climbing, so teams should track key metrics beyond traffic alone as AI visibility grows.
  • Among AI tools, Perplexity tends to deliver the highest volume of referral traffic, making it a priority surface for measurement.
  • A majority of mobile Google searches now end without a click across Google Search surfaces, as Google’s AI Overviews expand ai search results and featured answers resolve the query on the results page.

For a pharma marketing team, the implication is direct. The audience is moving to surfaces where the only currency is being the cited, trusted source. In a Your Money or Your Life category, where AI systems are deliberately conservative about which sources they quote, authoritative content is not a nice-to-have. It is the entry ticket.

How AEO Differs From Traditional SEO and GEO

Three terms now circulate in this space, and it is worth being precise about them because they shape strategy differently. In 2026, Google documented AEO as part of SEO, which accelerated adoption of the vocabulary across the industry.

Traditional SEO optimises web pages to rank in a list of organic search results, judged largely on relevance, domain authority, and backlinks. Generative engine optimization (GEO) is the broader umbrella discipline of earning visibility inside generative AI search across all generative engines. Answer engine optimization (AEO) is the sharpest expression of that goal: being the specific, cited answer inside an AI chat interface or AI Overview. Some practitioners use AEO and AI SEO interchangeably; the practical work overlaps heavily.

The mechanics diverge from classic SEO in concrete ways. AI crawlers and retrieval systems reward content that is machine-readable and easy to extract. Schema markup helps AI systems understand what a page is about and which facts it contains. Structured data turns prose into something a model can parse confidently. And rather than one long keyword-stuffed page, answer engines favour what practitioners call atomic content: short, self-contained paragraphs that each state a clear, extractable fact a model can lift directly into its response. Even so, the work still builds on SEO best practices and is increasingly discussed as AI search optimization, search optimization, and LLM SEO.

Answer Engine Optimization for Pharma: The Compliance-Shaped Version

Generic AEO advice tells you to publish fast, add FAQs, and chase brand mentions everywhere. None of that survives contact with MLR review. The pharma version of AEO has to be rebuilt around three realities that consumer marketers never face.

MLR review and the machine-readable mandate

Medical, Legal, and Regulatory review can take six to twelve weeks to clear a single piece of content, which rules out the high-velocity publishing cadence generic AEO assumes. The compliant response is to optimise the structure of fewer, higher-value pieces rather than the volume. When content does clear review, it should be engineered for extraction: schema markup applied, key facts stated atomically, FAQ blocks capturing the conversational queries HCPs actually prompt, bullet points for scannable structure, and clear formatting that presents direct answers to likely prompts so answer engines can extract accurate, in-context statements reliably. Updating cleared evergreen content every three to six months is also worth building into the calendar, since regular refreshes are associated with stronger citation rates in large language models. The MLR constraint becomes an advantage here: content that has survived legal and regulatory scrutiny is exactly the authoritative, accurate material AI systems are built to prefer.

HCPs are already prompting, not keywording

The keyword-to-prompt shift maps almost perfectly onto how healthcare professionals seek information. An HCP no longer searches “metformin contraindications”; they ask an assistant a full clinical question and expect a synthesised, sourced answer. Your keyword strategy has to evolve into a prompt-and-question strategy: start from user intent rather than isolated terms when planning content creation, map the conversational queries each audience segment poses, then build atomic, compliant answers to them, with creating content around real clinical questions improving fit with prompt-based retrieval. This is also where audience segmentation stays non-negotiable — the prompts an HCP issues, the language they use, and the sources they trust differ sharply from a patient’s, and conflating them produces content that gets cited for the wrong question.

E-E-A-T as citation currency

Google’s Quality Rater framework weights E-E-A-T — Experience, Expertise, Authoritativeness, and Trustworthiness — most heavily in Your Money or Your Life categories, and pharma sits squarely inside that classification. AI systems inherit this conservatism: they preferentially cite sources that carry strong authority and trust signals. For pharma, that means named authors with verifiable clinical or regulatory credentials, visible editorial and review processes, and consistent citation of authoritative bodies such as the EMA, ABPI, and FDA, with expert led content further strengthening citation trust. High citation authority is what signals to an AI model that your content is safe to quote. In practice, the E-E-A-T groundwork pharma teams already do for compliance doubles as the strongest possible AEO foundation, while also making content more ai friendly for systems evaluating authority and safety.

How to Optimize for Answer Engines: A Practical Framework

Bringing this together, here is a five-step framework for building answer engine optimization into a pharma content programme without breaching compliance.

Step 1: Map prompts, not just keywords

Start from the conversational queries each audience actually issues. Build a question map per segment — HCP, patient, payer — capturing the natural-language prompts that surface your therapy areas. Keyword volume still informs prioritisation, but the unit of work is now the question and the answer, not the term and the page.

Step 2: Structure content atomically and add schema

Write in extractable units. Lead key pages with a concise definitional answer of 40 to 60 words, use clear question-based subheadings, and keep one claim per paragraph. Apply structured data — FAQ Page, Medical Web Page, and relevant article schema — so AI crawlers can parse and trust your facts. Relevant images and other visual elements can also help explain complex material when they directly support the answer. This is the single highest-leverage technical move in AEO.

Step 3: Build authority AI systems will cite

Strengthen the trust signals that govern citation: named expert authors, transparent review processes, and references to authoritative regulatory and clinical sources, including authoritative citations that come from your own content as well as trusted third-party references. Pursue brand mentions and citations on credible industry domains, since answer engines weigh the authority of where you are referenced, not only your own domain authority, and in healthcare-adjacent contexts, properly moderated and relevant user generated content can sometimes support credibility.

Step 4: Align production with MLR reality

Plan content pipelines around review lead times. Prioritise evergreen, compliant educational content that will not need constant updating, and schedule the three-to-six-month refresh cycle that supports sustained LLM citation. Fewer pieces, optimised properly, beat a high-volume calendar that stalls in review.

Step 5: Measure the answer surface

Track where your content appears and is cited across AI engines, not only classic rankings. Monitor referral traffic from AI tools such as Perplexity, watch for brand mentions and citations inside newer interfaces like ai mode, and treat citation share — how often you are the quoted source — as a core metric alongside organic traffic.

Measuring AEO When the Click Disappears

The hardest adjustment is measurement. Traditional SEO leaned on clicks and sessions; AEO success often shows up as influence without a visit, because the user got their answer inside the AI interface. The practical response is to broaden the metric set. Referral traffic from AI-powered search engines is still measurable in Google Analytics and is a leading indicator. Beyond that, track brand mentions and citation frequency inside AI answers, monitor visibility across the major AI platforms, and accept that a meaningful share of value now accrues as zero-click brand authority. For pharma, where the goal is often being recognised as the trusted source on a therapy area rather than driving immediate transactions, that trade is more favourable than it first appears.

Where Capptoo Fits

Capptoo works inside the regulated world, not adjacent to it. We build answer engine optimization content for pharma and healthcare brands that combine traditional SEO with AI search optimization while respecting MLR realities and positioning your content to be the cited source across AI search.

We produce compliant prompt-and-question mapping, machine-readable content structured for extraction, schema implementation, and the E-E-A-T foundations that make AI systems comfortable quoting you.

If you are reassessing your search strategy for an AI-first world, our HCP Engagement and Website IQ services are built for exactly this transition. Start with our AEO readiness checklist to see whether your web content is structured for AI search optimization and how extractable and citable your current content really is.

Frequently Asked Questions

What is answer engine optimization?

Answer engine optimization (AEO) is the practice of structuring content so AI-powered search engines and large language models cite it directly in their generated answers. Rather than ranking in a list of links, AEO content is engineered to be the answer itself.

How is AEO different from traditional SEO?

Traditional SEO optimises pages to rank in a list of search results, judged on relevance, domain authority, and backlinks. AEO optimises content to be extracted and cited inside AI-generated answers, prioritising machine-readable structure, schema markup, and atomic, factual content.

What is the difference between prompting and keywording?

Keywording is compressing intent into a few terms to match against indexed pages and earn a click. Prompting is asking an AI engine a full natural-language question and receiving a synthesised, cited answer. The shift from one to the other is what makes AEO necessary.

Why does AEO matter specifically for pharma?

Healthcare professionals and patients are adopting prompt-based AI search quickly, and pharma sits in the Your Money or Your Life category where AI systems are most conservative about which sources they cite. Compliant, authoritative, well-structured content is what earns those citations.

Can pharma do AEO without breaching MLR compliance?

Yes. The compliant approach prioritises fewer, MLR-cleared, evergreen pieces structured for extraction — schema, atomic facts, and FAQ blocks — rather than high-velocity publishing. Content that has cleared regulatory review is exactly the authoritative material AI systems prefer to cite.